Lifevantage Profit Margin 2006-2019 | LFVN
Current and historical gross margin, operating margin and net profit margin for Lifevantage (LFVN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Lifevantage net profit margin as of September 30, 2019 is 3.65%.
| Lifevantage Annual Profit Margins |
|---|
| Lifevantage Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.213B | $0.226B |
| Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Becton Dickinson (BDX) | United States | $70.506B | 22.32 |
| McKesson (MCK) | United States | $25.635B | 10.16 |
| Align Technology (ALGN) | United States | $21.730B | 59.55 |
| AmerisourceBergen (ABC) | United States | $18.171B | 12.46 |
| Laboratory Of America Holdings (LH) | United States | $16.670B | 15.65 |
| Cardinal Health (CAH) | United States | $16.049B | 10.43 |
| Straumann Holding AG (SAUHF) | Switzerland | $15.257B | 0.00 |
| Cooper (COO) | United States | $15.229B | 24.87 |
| DENTSPLY SIRONA (XRAY) | United States | $12.911B | 25.24 |
| West Pharmaceutical Services (WST) | United States | $10.911B | 46.82 |
| Henry Schein (HSIC) | United States | $10.187B | 18.97 |
| CONMED (CNMD) | United States | $3.236B | 45.97 |
| Patterson (PDCO) | United States | $2.250B | 16.67 |
| STAAR Surgical (STAA) | United States | $1.662B | 86.79 |
| Merit Medical Systems (MMSI) | United States | $1.609B | 18.80 |
| Atrion (ATRI) | United States | $1.310B | 36.09 |
| Antares Pharma (ATRS) | United States | $0.798B | 489.00 |
| Invacare (IVC) | United States | $0.310B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.063B | 17.07 |
| Endologix (ELGX) | United States | $0.042B | 0.00 |
| Biolase (BIOL) | United States | $0.016B | 0.00 |
